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Abstract 27	
Animals regulate their physiology with respect to nutrient status, which requires 28	
nutrient sensing pathways. Simple carbohydrates, sugars, are sensed by the basic-helix-29	
loop-helix leucine zipper transcription factors ChREBP/Mondo, together with their 30	
heterodimerization partner Mlx, which are well-established activators of sugar-induced 31	
lipogenesis. Loss of ChREBP/Mondo-Mlx in mouse and Drosophila leads to sugar 32	
intolerance, i.e. inability to survive on sugar containing diet. Recent evidence has 33	
revealed that ChREBP/Mondo-Mlx responds to sugar and fatty acid-derived 34	
metabolites through several mechanisms and cross-connects with other nutrient sensing 35	
pathways. ChREBP/Mondo-Mlx controls several downstream transcription factors and 36	
hormones, which mediate not only readjustment of metabolic pathways, but also 37	
control feeding behavior, intestinal digestion, and circadian rhythm.  38	
 39	
Preface 40	
Nutrient intake of animals displays a high degree of variation, which requires fine-tuned 41	
control of metabolic pathways. Animals regulate their metabolic homeostasis by 42	
continuously reading and converging signals originating from both within the organism 43	
and the outside environment. Macronutrients (sugars, amino acids and lipids) are sensed 44	
by nutrient sensing pathways that detect different dietary inputs and orchestrate an 45	
integrated adaptive response that is appropriate for that particular set of macronutrients. 46	
Simple carbohydrates, sugars, are sensed by several mechanisms, of which the so-called 47	
intracellular sugar sensing by ChREBP/Mondo-Mlx transcription factors is among the 48	
most conserved ones. Studies from mouse and Drosophila have shown the importance 49	
of this system in providing sugar tolerance; animals lacking ChREBP/Mondo-Mlx die 50	
rapidly on a diet containing sugars at a level, which is normally physiologically 51	
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tolerated [1,2]. We highlight here recent work, which has revealed several novel aspects 52	
of the ChREBP/Mondo-Mlx physiological function and regulation by nutrient-derived 53	
cues. 54	
 55	
ChREBP/Mondo-Mlx – the conserved regulator of metabolic homeostasis  56	
Carbohydrate response element binding protein (ChREBP, also known as MondoB and 57	
MLXIPL) and its paralog MondoA (MLXIP) are intracellular sugar sensors that are 58	
activated by glucose-6-phosphate (G6P) and other phosphorylated hexoses [3]. 59	
ChREBP and MondoA act together with their common heterodimerization partner Mlx, 60	
a necessary step for transcriptional activation. Although both are ubiquitously 61	
expressed, ChREBP is more prominently expressed in the liver and adipose tissue 62	
whereas MondoA is most highly expressed in the skeletal muscle. Muscle breaks down 63	
glucose via the glycolytic pathway to release energy that is used for muscle contraction 64	
and in fact many of the MondoA-Mlx target genes are involved in the glycolytic 65	
pathway [4,5]. Liver is the main site for de novo lipogenesis (DNL), where dietary 66	
sugars are converted into triacylglycerols (TAGs) and further transported to adipose 67	
tissue for storage. ChREBP target genes include lipogenic genes, such as fatty acid 68	
synthase and acetyl-CoA-carboxylase, both of which possess well-established 69	
ChREBP-Mlx binding sites, known as the carbohydrate response element (ChoRE), in 70	
their promoters [6,7]. ChREBP-Mlx is also a key regulator of glycolytic genes, such as 71	
glucokinase regulatory protein, glyceraldehyde-3-phosphate dehydrogenase and L-72	
type pyruvate kinase, in the liver and adipose tissue [6-10]. Moreover, ChREBP-Mlx 73	
regulates the glucose-induced expression of glucose-6-phosphate dehydrogenase 74	
(G6PDH), the rate-limiting enzyme of the pentose phosphate pathway (PPP) [8].  75	
 76	
The physiological function and key metabolic target genes of ChREBP/Mondo-Mlx are 77	
well conserved in animals and studies in Drosophila have revealed new insight into the 78	
physiological roles and tissue specificity of intracellular sugar sensing. Whereas the 79	
vertebrate genome encodes for two Mondo proteins, the fruit fly, Drosophila, has only 80	
one Mondo protein, displaying high expression in the fat body (corresponding to liver 81	
and adipose tissue), midgut (corresponding to small intestine) and Malpighian tubules 82	
(corresponding to kidney) [2]. Mondo-Mlx mediates a substantial proportion of 83	
Drosophila sugar-induced transcription and it activates conserved genes involved in 84	
glycolysis, lipogenesis, and the PPP, which is the most strongly over-represented 85	
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Mondo-Mlx target pathway in Drosophila [11]. The PPP has a key role in producing 86	
NADPH reductive power, which is needed for the biosynthesis of lipids. Indeed, 87	
inhibition of the Mondo-Mlx induced activation of glucose-6-phosphate dehydrogenase 88	
leads to a dramatic reduction of TAG stores in Drosophila larvae [11]. The PPP is also 89	
essential for sugar tolerance. The reductive power of NADPH generated by the PPP 90	
prevents oxidative damage upon high sugar feeding through the glutathione system, 91	
which contributes to the animal’s ability to tolerate a high sugar diet [11,12]. 92	
 93	
In addition to conserved metabolic pathways, studies in Drosophila have revealed novel 94	
tissue-specific functions for sugar sensing. Mondo-Mlx is essential for the sugar-95	
induced regulation of digestive enzymes in the midgut. Sugar feeding represses the 96	
expression of Amylases and Maltases, which are needed for digestion of complex 97	
carbohydrates [13,14]. This mechanism might have a role in regulating glucose intake, 98	
in order to prevent glucose overload [15]. Mondo-Mlx also regulates Malpighian 99	
tubule-specific glucose transporters, possibly in order to control excretion of excess 100	
glucose [11]. Furthermore, Mondo-Mlx is essential for normal flight muscle function 101	
and structure. Muscle-specific knockdown leads to accumulation of glycogen stores, 102	
possibly reflecting reduced glucose utilization [16]. In conclusion, ChREBP/Mondo-103	
Mlx is a conserved sugar sensor within animals, with essential roles in sugar-induced 104	
lipogenesis and coordinating whole body glucose homeostasis by controlling 105	
carbohydrate digestion and transport.  106	
 107	
ChREBP/Mondo-Mlx controls a gene regulatory network 108	
In addition to direct regulation of key metabolic genes Mondo-Mlx is emerging as a 109	
master regulator of other regulatory genes, including transcription factors (TFs) (Figure 110	
1). Mondo-Mlx directly regulates Krüppel-like factor 10 (KLF10, also known as 111	
TIEG1) and its Drosophila ortholog Cabut. In Drosophila, the cabut promoter has two 112	
high affinity ChoREs. cabut is the most strongly downregulated gene in mlx mutants 113	
and depletion of Cabut by RNAi induces sugar intolerance in Drosophila larvae [2]. 114	
Similarly, in rat primary hepatocytes KLF10 expression is activated by glucose 115	
stimulation and hampered by dominant negative Mlx [17]. Elevated KLF10 expression 116	
is also observed in vivo in mouse following feeding on a high fat/high sugar diet [18]. 117	
Adenoviral overexpression of KLF10 in primary hepatocytes suppressed the glucose-118	
induced activation of ChREBP and several of its target genes, suggesting that KLF10 119	
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can act as a negative feedback regulator of ChREBP [17]. A different outcome was 120	
observed in loss-of-function experiments in Drosophila, where Cabut mediated 121	
downregulation of a gene set in response to sugar feeding [19]. Among the most 122	
strongly repressed Cabut target genes was phosphoenolpyruvate carboxykinase 123	
(pepck), which is a direct Cabut target and also a target of KLF10 in mouse [19,20]. 124	
PEPCK is the rate-limiting enzyme of cataplerotic flux from the TCA cycle to mediate 125	
channeling of carbon towards gluco- and glyceroneogenesis. Consistent with high 126	
expression of pepck, Drosophila mlx mutants display high levels of glycerol and 127	
trehalose (a circulating form of glucose in insects), which could be suppressed by 128	
simultaneous loss of pepck [19]. Interestingly, Cabut also links sugar sensing to 129	
regulation of circadian rhythm. Deregulation of Cabut has a dramatic impact on the 130	
cycling of circadian metabolic gene output, while having no impact on the cycling of 131	
core clock genes [19]. Notably, in rat hepatocytes ChREBP-Mlx also directly regulates 132	
BHLHB2/DEC1, which has a well-established role in circadian regulation [21,22]. In 133	
conclusion, through direct regulation of downstream transcription factors, 134	
ChREBP/Mondo-Mlx-mediated sugar sensing appears to be closely coupled to the 135	
circadian clock. Considering the observations on re-setting of the peripheral circadian 136	
clock through timed feeding [23], it will be interesting to further explore the 137	
physiological importance of the observed interplay between these TFs.  138	
 139	
ChREBP/Mondo-Mlx also controls the expression of TFs involved in lipid 140	
homeostasis. The Gli-similar (GLIS) transcription factor Sugarbabe has been long 141	
known as the earliest and strongest sugar-responsive gene in Drosophila [14]. Recently, 142	
sugarbabe was found to be a direct target of Mondo-Mlx. Loss- and gain of function 143	
analyses revealed that Sugarbabe contributes to the lipid homeostasis in vivo. It 144	
regulates fatty acid synthesis downstream of Mondo-Mlx by inducing the expression of 145	
lipogenic genes ACC, FAS, AcCoAS and ATPCL in response to sugar feeding [11]. Gli-146	
similar transcription factor 2, the closest human homologue of Sugarbabe, was 147	
originally identified as a bifunctional transcription factor, regulating both the activation 148	
and repression of its target genes involved in kidney development [24]. Interestingly, 149	
variants of another sugarbabe homolog, GLIS3, are now established as one of the 150	
strongest known genetic risk factors for both type 1 and type 2 diabetes [25]. In addition 151	
to direct regulation of other TFs, ChREBP-Mlx also regulates downstream effectors 152	
indirectly. One such example is the fatty acid responsive nuclear receptor PPARγ [26]. 153	
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ChREBP expression is elevated during adipocyte differentiation and ChREBP activity 154	
is needed to maintain maximal transcriptional output of adipogenic PPARγ. 155	
Consequently, ectopic activation of ChREBP promotes adipocyte differentiation. 156	
ChREBP likely affects PPARγ indirectly through lipid biosynthesis as the activating 157	
effects of ChREBP depend on functional Fatty acid synthase [26]. In conclusion, 158	
ChREBP/Mondo-Mlx contributes to lipid homeostasis through its direct targets as well 159	
as through secondary TFs. 160	
 161	
New hormonal targets of ChREBP/Mondo-Mlx  162	
In addition to downstream transcription factors, ChREBP/Mondo-Mlx contributes to 163	
systemic regulation through hormonal signals, including FGF21. In cultured 164	
hepatocytes ChREBP-Mlx regulates the expression of FGF21 in a glucose-dependent 165	
manner [8,27]. Levels of circulating FGF21 are rapidly increased in response to 166	
fructose in humans as well as mice [28,29]. Interestingly, both baseline and fructose-167	
stimulated levels of FGF21 are significantly elevated in subjects with metabolic 168	
syndrome [28]. This is consistent with findings showing elevated activation of hepatic 169	
ChREBP in obese individuals [30]. Loss of FGF21 in turn leads to impaired de novo 170	
lipogenesis in mouse liver, which is accompanied by liver fibrosis following prolonged 171	
fructose exposure [29]. In addition to metabolic regulation, FGF21 also regulates sugar 172	
feeding. Mice lacking FGF21 consume elevated levels of sucrose, whereas ectopic 173	
FGF21 suppresses the intake of sugar in mice as well as cynomolgus monkeys [31,32]. 174	
The liver-derived FGF21 suppresses sugar feeding in mice by acting through the FGF21 175	
receptor complex in the paraventricular nucleus of the hypothalamus [31]. A similar 176	
regulatory system likely exists in humans, since variants of FGF21 are strongly 177	
associated with sweet preference, as judged by the consumption of candy [33].  178	
 179	
Research in Drosophila has revealed new connections between Mondo-Mlx and 180	
hormonal metabolic regulation via TGF-b/Activin signaling. TGF-b/Activin ligand 181	
Dawdle is highly expressed in the Drosophila fat body, from where it is secreted [15]. 182	
Sugar feeding strongly elevates dawdle expression, while loss of mlx leads to impaired 183	
dawdle activation [11,15]. Moreover, Mondo-Mlx directly binds to a ChoRE at the 184	
dawdle promoter [11]. Dawdle is essential in metabolic regulation as mutants of dawdle 185	
show elevated circulating trehalose and glucose as well as high levels of glycogen and 186	
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triacylglycerol [34]. Dawdle acts through multiple target tissues, for example it acts on 187	
Drosophila insulin producing cells to promote insulin-like peptide secretion [34]. 188	
Moreover, Dawdle activates its receptor Baboon in intestinal enterocytes and 189	
suppresses the expression of genes encoding carbohydrate digestive enzymes, 190	
Amylases and Maltases, thus inhibiting carbohydrate digestion in response to excess 191	
systemic glucose [15]. Interestingly, Dawdle functionally cooperates with the Mondo-192	
Mlx target TF Sugarbabe, which also contributes to the sugar-induced repression of 193	
amylase expression [11]. In conclusion, studies in mammals and Drosophila have 194	
opened new insight into the role of ChREBP/Mondo-Mlx on the systemic regulation of 195	
metabolism via hormones secreted by the liver and fat body, respectively. 196	
 197	
Direct regulation of ChREBP/Mondo-Mlx by nutrient-derived cues 198	
ChREBP/Mondo TFs respond to sugars via their N-terminal Glucose sensing module 199	
(GSM), which can be functionally divided into low-glucose inhibitory domain (LID) 200	
and glucose response activation conserved element (GRACE) [35]. Although direct 201	
structural evidence about ChREBP/Mondo activation mechanism is still missing, ample 202	
indirect evidence suggests that direct binding of G6P, and possibly other 203	
phosphorylated hexoses, lead to loss of intramolecular inhibition of GRACE by LID 204	
[36,37]. Subsequently activated ChREBP/Mondo-Mlx dissociates from 14-3-3, 205	
translocates to the nucleus, and binds to the ChoRE to activate its target genes (Figure 206	
2A) [38-40]. Furthermore, glucose-responsive dephosphorylation as well as acetylation 207	
have also been shown to contribute to ChREBP activation [41,42]. A detailed 208	
representation of ChREBP/Mondo-Mlx activation has been presented elsewhere [3]. 209	
This core activation mechanism allows ChREBP/Mondo-Mlx to control gene 210	
expression in response to sugar availability. However, additional regulatory 211	
mechanisms and functional interplay with other nutrient-responsive TFs to integrate 212	
other nutrient-derived signals are beginning to emerge. One such signaling mechanism 213	
is O-GlcNacylation. The synthesis of the substrate for O-GlcNacylation, UDP-GlcNAc, 214	
through the hexosamine biosynthesis pathway (HBP), depends on availability of 215	
nutrients, such as glucose and glutamine [43]. Thereby, O-GlcNacylation is considered 216	
as a nutrient sensing mechanism. ChREBP is O-GlcNac modified [44-46] and recent 217	
mass-spectrometric analysis have revealed multiple target sites [47]. Consistent with 218	
the glucose sensitivity of the HBP, the levels of ChREBP O-GlcNac modification are 219	
increased upon exposure to high glucose [44,45]. O-GlcNac modification increases 220	
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ChREBP protein stability and increases the expression of ChREBP target genes [44]. 221	
Pancreatic b-cells have an inherent glucose sensing capacity and ChREBP activation 222	
seems to involve a distinct mechanism in this setting. ChREBP forms a cytoplasmic 223	
complex with a Calcium binding protein Sorcin [48]. Calcium influx in response to 224	
high glucose releases ChREBP allowing its nuclear localization. In conclusion, 225	
ChREBP activity is regulated by sugars through multiple parallel mechanisms. 226	
 227	
In addition to posttranslational modifications, ChREBP/Mondo-Mlx is also regulated 228	
at the transcriptional level. In mammals, the ChREBP gene encodes two isoforms, 229	
ChREBP-a and ChREBP-b, which are transcribed from different promoters [49]. 230	
ChREBP-a is contains the N-terminal GSM and is thus directly activated by G6P. 231	
ChREBP-a stimulates the expression of the shorter ChREBP-b, which lacks inherent 232	
glucose sensing ability, but has a 20-fold higher transcriptional activity than ChREBP-233	
a. The promoter of ChREBP contains a binding site for Liver X receptor (LXR), and it 234	
has been shown that LXR regulates the expression of ChREBP in the liver [50,51]. 235	
However, the effect of LXR on ChREBP expression appears to be independent of 236	
nutrient as the expression of ChREBP is not altered in high-sugar fed LXR mutant mice 237	
[52]. Hepatocyte nuclear factor 4 alpha (HNF-4a) in turn has been shown to activate 238	
the expression of both ChREBP isoforms in response to glucose [53]. Moreover, HNF-239	
4a has been also shown to physically interact with ChREBP, and this interaction is 240	
promoted by glucose [53,54]. 241	
 242	
While ChREBP is activated in the liver of animals on a high sugar diet, a high lipid diet 243	
has an inhibitory effect. Furthermore, administration of fatty acids inhibits nuclear 244	
translocation and activation of ChREBP (Figure 2B) [55,56]. Fatty acids are oxidized 245	
into ketone bodies, such as β-hydroxybutyrate and acetoacetate. By using an in vitro 246	
binding assay with purified ChREBP and 14-3-3 as well as protein-free hepatocyte 247	
extracts, Nagakawa and coworkers showed that β-hydroxybutyrate and acetoacetate 248	
increase the binding between ChREBP and 14-3-3 [57]. This increased binding anchors 249	
ChREBP to the cytoplasm, preventing its target gene activation. Fatty acid 250	
administration also significantly elevates the levels of intracellular AMP [55]. AMP 251	
activates the AMP-activated protein kinase (AMPK), which phosphorylates ChREBP 252	
on Ser568 and inhibits its transcriptional activity, while having no impact on the nuclear 253	
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localization [55,58]. Interestingly, a recent study suggests that AMP can also inhibit 254	
ChREBP directly, through an allosteric mechanism. AMP binds to ChREBP and 255	
increases its affinity to 14-3-3, which prevents ChREBP nuclear translocation [58]. In 256	
conclusion, recent studies suggest that ChREBP acts as a direct sensor for several fatty 257	
acid-derived metabolites, thus integrating multiple nutrient-derived cues.  258	
 259	
Cross-talk between ChREBP and other nutrient sensing pathways 260	
In addition to nutrient sensing through direct allosteric regulation and posttranslational 261	
mechanisms, ChREBP/Mondo acts in close synergy with other nutrient sensing 262	
systems, including insulin signaling. A well-established example is SREBP, a target of 263	
insulin signaling, which controls synergistically lipogenic gene expression with 264	
ChREBP [59]. In Drosophila, Mondo was shown to act synergistically with Salt-265	
inducible kinase 3 (SIK3), which is also a target of the insulin signaling pathway 266	
[12,60]. Mondo and SIK3 act cooperatively to activate the PPP upon sugar feeding [12]. 267	
Similarly to Mondo, SIK3 is essential for sugar tolerance and animals with reduced 268	
expression of both Mondo and SIK3 display extremely low tolerance towards dietary 269	
sugars [12]. Moreover, ChREBP O-GlcNacylation is inhibited by Foxo1, which is an 270	
inhibitory target of insulin signaling, thus providing additional cross-talk between 271	
insulin-mediated systemic glucose homeostasis and intracellular glucose sensing [46]. 272	
ChREBP also likely modulates insulin signaling, since genome-wide analysis of 273	
ChREBP chromatin binding in mouse liver and adipose tissue revealed significant 274	
enrichment in ChREBP binding near genes encoding components of the insulin 275	
signaling pathway [61]. 276	
 277	
Evidence about cross-talk between sugar sensing and amino acid sensing is also 278	
emerging (Figure 2C). Glutamine is a critical metabolic intermediate, acting as a carbon 279	
and ammonium carrier. Glutaminolysis is critical in replenishing the TCA cycle, when 280	
TCA cycle carbon is channeled to biosynthesis. Interestingly, glutamine modifies 281	
glucose sensing by inhibiting the transcriptional output of MondoA [62]. Consequently, 282	
glutamine inhibits the glucose-induced activation of TXNIP, a negative regulator of 283	
glucose transporter GLUT1 [63], thus increasing cellular glucose uptake [62]. 284	
Glutamine has no impact on MondoA nuclear localization or DNA binding, but it likely 285	
impacts MondoA cofactors [62]. MondoA can also control the uptake of glutamine. In 286	
endothelial cells infected with Kaposi's Sarcoma-associated Herpesvirus, glutamine 287	
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transporter SLC1A5 is activated in a MondoA-Mlx-dependent manner to facilitate 288	
glutaminolysis [64]. In conclusion, MondoA coordinates the intracellular balance of 289	
glucose and glutamine catabolism. 290	
 291	
The mechanistic target of rapamycin (mTOR) is a conserved intracellular amino acid 292	
sensing system, which also has been shown to modulate the output of ChREBP/Mondo-293	
Mlx. mTOR inhibitors increase the expression of MondoA-Mlx target gene TXNIP 294	
[65]. mTOR physically interacts with MondoA and sequesters it from forming an active 295	
complex with Mlx [65]. Similarly to MondoA, ChREBP is inhibited by mTOR through 296	
protein-protein interaction [66]. mTOR inhibition leads to increased expression of 297	
TXNIP, which causes death of pancreatic b-cells [66]. Interestingly, the levels of 298	
TXNIP are strongly elevated in diabetic islets, further suggesting that retaining the 299	
interaction between cellular amino acid and glucose sensing is essential for normal b-300	
cell homeostasis. Recent evidence from C. elegans implies that Mondo-Mlx has a 301	
capacity to modulate mTOR signaling, since loss of C. elegans homolog of Mondo and 302	
Myc, MLL-1, leads to mTOR activation [67]. MLL-1 represses the expression of 303	
leucyl-tRNA synthetase lars-1, whose activity promotes mTOR activation via RAG-304	
GTPases [67,68]. Through the regulation of mTOR signaling, MLL-1 is essential for 305	
promoting longevity [67]. In sum, mTOR and ChREBP/Mondo pathways appear to be 306	
closely interconnected, which potentially provides cross-coordination between 307	
phenotypic outputs of dietary sugars and amino acids. 308	
 309	
Concluding remarks 310	
To conclude, recent work in the field has revealed that ChREBP/Mondo-Mlx regulates 311	
a large regulatory network, including transcription factors and hormones, which 312	
controls not only metabolic pathways, but also feeding activity and intestinal digestion. 313	
In addition to intracellular sugar sensing, ChREBP/Mondo-Mlx integrates multiple 314	
nutrient-responsive inputs, placing it at the very heart of an interlinked regulatory 315	
system mediating physiological re-adjustment in response to nutrient intake. Such 316	
integrated control allows animals to flourish in highly variable nutrient landscapes.  317	
 318	
However, several questions remain to be addressed. These include elucidating the 319	
structural basis of the function of the Glucose sensing module. This would allow better 320	
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understanding of the “nutrient sensor” mechanism of ChREBP/Mondo and possibly to 321	
enable design of new pharmaceuticals to modulate its activity. Given the availability of 322	
animal models, understanding of the physiological roles of ChREBP/Mondo in 323	
different tissues and cell types will certainly arise. Moreover, a wider perspective is 324	
needed to understand the natural variation in dietary sugar intake, and the variation 325	
between species and individuals with respect to their healthy nutrient landscape. As 326	
ChREBP/Mondo-Mlx is a key determinant in sugar tolerance in mice and Drosophila, 327	
it will be interesting to analyze its function in animals with differential sugar intake - 328	
and perhaps differential inherent sugar tolerance. Understanding the genetic factors 329	
predisposing humans to disease on a high sugar diet would allow disease prevention 330	
through personalized nutrition.  331	
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 355	
Figures 356	
 357	
 358	
 359	
Figure 1. ChREBP/Mondo-Mlx is a master regulator of a sugar-induced gene 360	
regulatory network. In response to sugars, ChREBP/Mondo-Mlx activates the 361	
expression of a number of metabolic genes, but also other regulatory genes involved in 362	
the control of carbohydrate and lipid metabolism, sugar feeding and circadian rhythm. 363	
The figure summarizes key targets of mammalian ChREBP and MondoA as well as 364	
Drosophila Mondo. Abbreviations: ACC: acetyl-CoA carboxylase, Cbt: Cabut, DEC1: 365	
deleted in esophageal cancer 1, FAS: fatty acid synthase, FGF21: fibroblast growth 366	
factor 21, G6PDH: glucose-6-phosphate dehydrogenase, KLF10: krüppel-like factor 367	
10, L-PK: L-type pyruvate kinase, PEPCK: phosphoenolpyruvate carboxykinase, 368	
PPARg: peroxisome proliferator-activated receptor gamma, TXNIP: thioredoxin-369	
interacting protein. 370	
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 372	
 373	
 374	
Figure 2. ChREBP/Mondo-Mlx activity is regulated by many nutrient-derived 375	
cues. ChREBP/Mondo-Mlx is activated by glucose-6-phosphate (G6P) (A) and 376	
inhibited both by ketone bodies and AMP, whose levels depend on fatty acids (B). 377	
Direct binding of TOR to MondoA and ChREBP inhibits their function and glutamine 378	
inhibits the transcriptional activity of ChREBP-Mlx (C).  379	
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